Unaudited Condensed Statements of Cash Flows - USD ($)	5 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2020
Cash flows from operating activities:
Net income / (loss)	$ 1,161,222	$ (4,061,354)
Adjustments to reconcile net income / (loss) to net cash used in operating activities:
Interest income earned on marketable securities held in Trust Account	(1,693,512)	(1,703,007)
Change in operating assets and liabilities:
Prepaid expenses	(366,667)	150,000
Prepaid income taxes		(240,368)
Accounts payable and accrued expenses	102,125	4,521,248
Accounts payable - related party	52,256	120,116
Income taxes payable	345,918
Net cash used in operating activities	(398,658)	(1,213,365)
Cash flows from investing activities:
Cash deposited in Trust Account	(450,000,000)
Investment income released from Trust Account	210,000	777,287
Net cash provided by / (used in) investing activities	(449,790,000)	777,287
Cash flows from financing activities:
Proceeds from sale of Class A common stock to public	450,000,000
Proceeds from sale of Private Placement Warrants to Sponsor	11,000,000
Payment of underwriters’ discount	(9,000,000)
Payment of offering costs	(587,474)
Proceeds from promissory note – related party	141,636
Payment of offering costs	(141,636)
Net cash provided by financing activities	451,412,526
Net change in cash and cash equivalents	1,223,868	(436,078)
Cash and cash equivalents at beginning of period		951,060
Cash and cash equivalents at end of period	1,223,868	514,982
Supplemental disclosure of noncash investing and financing activities:
Change in value of Class A common stock subject to possible redemption	431,823,740	(4,061,350)
Deferred underwriting commission in connection with initial public offering	15,750,000	15,750,000
Deferred offering costs paid by Sponsor in exchange for issuance of Class B common stock	$ 25,000